Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients With Recurrent Glioma

NCT01011231 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01011231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients With Recurrent Glioma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2009
Completion date
April 30, 2011
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma